PKC-theta function in RORgammat-regulated Th17 differentiation
PKC-theta function in RORgammat-regulated Th17 differentiation
批准号:
8760288
负责人:
Zuoming Sun
金额:
$41.5万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-06-01 至 2016-10-31
关键词:
AgreementAnimal ModelAutoimmune DiseasesAutoimmunityCell physiologyCellsCellular biologyCollaborationsDataDevelopmentDrug TargetingEquilibriumExperimental Autoimmune EncephalomyelitisGenerationsGoalsHealthImmune responseImmune systemImmunityIn VitroInflammatoryKnowledgeLearningMediatingModelingMolecularMultiple SclerosisNuclear Orphan ReceptorPharmacologic SubstancePhosphorylationPreventionProtein Kinase CReceptor ActivationReceptor SignalingRecruitment ActivityRegulationRegulatory T-LymphocyteResearchRetinoidsRoleSteroid ReceptorsT-Cell ReceptorT-LymphocyteTestingTherapeuticTherapeutic UsesTimeWorkabstractingarmbaseclinical applicationin vivoinhibitor/antagonistinnovationmouse modelnovelpathogenprevent
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Abstract Generation of robust Th17 immune responses required for clearance of certain pathogens depends on promoting Th17 while reciprocally inhibiting Treg formation. Whereas, effective prevention of Th17-mediated autoimmunity such as EAE depends on inhibiting pathogenic Th17 while reciprocally promoting Treg formation. However, little is known about the mechanisms responsible for coordination of Th17 and Treg differentiation. Our preliminary results demonstrated that PKC-theta is a critical checkpoint for reciprocal Th17 and Treg differentiation. The proposed studies will investigate the function of PKC- theta and RORyt in the reciprocal Th17 and iTreg differentiation. Based on the knowledge learned from the studies, we expect to develop PKC-8-based treatments for prevention of EAE, an animal model of multiple sclerosis. It is expected that such treatments will have a broader applicability in the prevention of Th17-mediated autoimmunity. In addition, the proposed research has significance to basic T cell biology, as it is expected to reveal novel molecular mechanisms for PKC- theta -mediated TCR signals in the coordination of Th17 and iTreg differentiation.
期刊论文(19)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1371/journal.pone.0031174
发表时间:
2012
期刊:
PloS one
影响因子:
3.7
作者:
[Fang X, Wang R, Ma J, Ding Y, Shang W, Sun Z]
通讯作者:
Sun Z
DOI:
10.1615/critrevimmunol.v26.i6.10
发表时间:
2006
期刊:
Critical reviews in immunology
影响因子:
1.3
作者:
[H. Xie;Zhaofeng Huang;Ruiqing Wang;Zuoming Sun]
通讯作者:
H. Xie;Zhaofeng Huang;Ruiqing Wang;Zuoming Sun
DOI:
10.4049/jimmunol.181.1.513
发表时间:
2008-07-01
期刊:
JOURNAL OF IMMUNOLOGY
影响因子:
4.4
作者:
[Manicassamy, Santhakumar, Yin, Dengping, Zhang, Zheng, Molinero, Luciana L., Alegre, Marisa-Luisa, Sun, Zuoming]
通讯作者:
Sun, Zuoming
DOI:
10.4049/jimmunol.1102941
发表时间:
2012-06-15
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
[Kwon MJ, Ma J, Ding Y, Wang R, Sun Z]
通讯作者:
Sun Z
DOI:
10.2174/1871530311006040367
发表时间:
2010-12
期刊:
Endocrine, metabolic & immune disorders drug targets
影响因子:
--
作者:
[Kwon MJ, Wang R, Ma J, Sun Z]
通讯作者:
Sun Z
共 13 条
Function of TCF-1 in antagonizing malignancy
-
批准号:10435550
-
项目类别:
-
资助金额:$26.4万
-
财政年份:2021
-
负责人:Zuoming Sun
-
依托单位:
Function of TCF-1 in antagonizing malignancy
-
批准号:10281056
-
项目类别:
-
资助金额:$22.0万
-
财政年份:2021
-
负责人:Zuoming Sun
-
依托单位:
Differential mechanisms for RORgammat-regulated thymocyte development and Th17 di
-
批准号:9265772
-
项目类别:
-
资助金额:$42.0万
-
财政年份:2014
-
负责人:Zuoming Sun
-
依托单位:
Differential mechanisms for RORgammat-regulated thymocyte development and Th17 di
-
批准号:8635224
-
项目类别:
-
资助金额:$42.0万
-
财政年份:2014
-
负责人:Zuoming Sun
-
依托单位:
Steroid nuclear receptor coactivators in T cell differentiation
-
批准号:10597251
-
项目类别:
-
资助金额:$51.02万
-
财政年份:2014
-
负责人:Zuoming Sun
-
依托单位:
Differential mechanisms for RORgammat-regulated thymocyte development and Th17 di
-
批准号:8810643
-
项目类别:
-
资助金额:$42.0万
-
财政年份:2014
-
负责人:Zuoming Sun
-
依托单位:
Steroid nuclear receptor coactivators in T cell differentiation
-
批准号:10152513
-
项目类别:
-
资助金额:$51.02万
-
财政年份:2014
-
负责人:Zuoming Sun
-
依托单位:
Steroid nuclear receptor coactivators in T cell differentiation
-
批准号:10392370
-
项目类别:
-
资助金额:$51.02万
-
财政年份:2014
-
负责人:Zuoming Sun
-
依托单位:
Dissecting PKC-theta-regulated T cell functions in allograft rejection
-
批准号:8123649
-
项目类别:
-
资助金额:$41.5万
-
财政年份:2010
-
负责人:Zuoming Sun
-
依托单位:
In vivo Analysis of RORgamma mediated Functions
-
批准号:7623766
-
项目类别:
-
资助金额:$34.31万
-
财政年份:2004
-
负责人:Zuoming Sun
-
依托单位:
PKC-theta function in RORgammat-regulated Th17 differentiation
-
批准号:8580188
-
项目类别:
-
资助金额:$41.5万
-
财政年份:2004
-
负责人:Zuoming Sun
-
依托单位:
In vivo Analysis of RORgamma mediated Functions
-
批准号:6824560
-
项目类别:
-
资助金额:$33.93万
-
财政年份:2004
-
负责人:Zuoming Sun
-
依托单位:
PKC-theta function in RORgammat-regulated Th17 differentiation
-
批准号:8044512
-
项目类别:
-
资助金额:$41.5万
-
财政年份:2004
-
负责人:Zuoming Sun
-
依托单位:
In vivo Analysis of RORgamma mediated Functions
-
批准号:7068082
-
项目类别:
-
资助金额:$33.62万
-
财政年份:2004
-
负责人:Zuoming Sun
-
依托单位:
PKC-theta function in RORgammat-regulated Th17 differentiation
-
批准号:8196909
-
项目类别:
-
资助金额:$41.5万
-
财政年份:2004
-
负责人:Zuoming Sun
-
依托单位:
In vivo Analysis of RORgamma mediated Functions
-
批准号:7235405
-
项目类别:
-
资助金额:$32.64万
-
财政年份:2004
-
负责人:Zuoming Sun
-
依托单位:
PKC-theta function in RORgammat-regulated Th17 differentiation
-
批准号:8369863
-
项目类别:
-
资助金额:$39.01万
-
财政年份:2004
-
负责人:Zuoming Sun
-
依托单位:
In vivo Analysis of RORgamma mediated Functions
-
批准号:6894294
-
项目类别:
-
资助金额:$34.43万
-
财政年份:2004
-
负责人:Zuoming Sun
-
依托单位:
海外基金